Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2012
09/18/2012CA2616589C Compositions for the reversible thioesterification of signaling proteins and methods of using same
09/18/2012CA2614326C Compositions and methods relating to orthogonal ribosome mrna pairs
09/18/2012CA2574866C Detection of microorganisms with a fluorescence-based device
09/18/2012CA2474146C A method for evolving a cell having desired phenotype and evolved cells
09/18/2012CA2454807C Cultured cell construct which contains spheroids of cultured animal cells and the use thereof
09/18/2012CA2448647C Developmental animal model of temporal lobe epilepsy
09/18/2012CA2447222C Polynucleotide sequencing method
09/18/2012CA2374385C Detection of hiv-1 by nucleic acid amplification
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2294962C Nucleic acid sequence analysis
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/13/2012WO2012122571A1 Methods and compositions for the selection and optimization of oligonucleotide tag sequences
09/13/2012WO2012122564A2 Diagnostic and sample preparation devices and methods
09/13/2012WO2012122561A2 Methods and systems for spores detection
09/13/2012WO2012122559A2 Method and apparatus for treating containers
09/13/2012WO2012122525A1 Process controls for molecular assay
09/13/2012WO2012122447A1 Methods of using microrna-26a to promote angiogenesis
09/13/2012WO2012122436A2 Molecular zipper tweezers and spring devices
09/13/2012WO2012122412A2 Compositions for reducing risk of adverse events caused by drug-drug interactions
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122379A2 Microfluidic cytochemical staining system
09/13/2012WO2012122378A2 Antibody-like proteins for therapeutic and diagnostic use
09/13/2012WO2012122314A2 Rapid cell purification systems
09/13/2012WO2012122290A2 Citrus greening (huanglongbing)-induced small rnas are potential early diagnosis markers
09/13/2012WO2012122236A2 Method and system to detect and diagnose alzheimer's disease
09/13/2012WO2012122219A2 Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker
09/13/2012WO2012122135A2 Apparatus and process for isolating specific physical items within a set of physical items
09/13/2012WO2012122127A2 Personalized medical management system, networks, and methods
09/13/2012WO2012122017A2 Method for rapid identification of drug targets and drug mechanisms of action in human cells
09/13/2012WO2012122015A2 Selective inhibitors of tumor-initiating cells
09/13/2012WO2012121978A2 Biomarkers for the diagnosis of lacunar stroke
09/13/2012WO2012121746A2 Imaging beta cell mass
09/13/2012WO2012121725A1 Biologically self-assembled nanotubes
09/13/2012WO2012121679A1 Method of modulating phenotype of a renal cell cancer-associated monocyte or macrophage
09/13/2012WO2012121486A2 Gene analysis method using sdl-pcr
09/13/2012WO2012121429A1 Method for cancer cell biomarker identification, and an nmd-irrelevant cancer cell biomarker identified by means of the method
09/13/2012WO2012121396A1 Fluorescent probe and use thereof
09/13/2012WO2012121392A1 Azophosphorus compound and azole compound library and method for producing same
09/13/2012WO2012121324A1 Method for selecting effective group of cancer treatments combining use of three agents of taxane-based anticancer agent, platinum complex-based anticancer agent, and pyrimidine fluoride-based anticancer agent
09/13/2012WO2012121261A1 Method for screening for compound capable of enhancing or inhibiting oatp1b1 transport activity, and method for determining expression level of oatp1b1
09/13/2012WO2012121225A1 Nucleic acid detection method, and device and kit for use in same
09/13/2012WO2012121178A1 Tumor angiogenesis inhibitor
09/13/2012WO2012121150A1 Hydrogen peroxide resistance-imparting gene and method for using same
09/13/2012WO2012121144A1 Method of analyzing l-tryptophan in biological samples, and kit used therein
09/13/2012WO2012120517A1 Methods and devices for handling biofouling
09/13/2012WO2012120463A1 Fluidic centripetal device
09/13/2012WO2012120387A1 Rapid quantification of biomolecules in a selectively functionalized nanofluidic biosensor and method thereof
09/13/2012WO2012120377A2 Molecular biomarker set for early detection of ovarian cancer
09/13/2012WO2012120374A2 Methods and biomarkers for detection of gastrointestinal cancers
09/13/2012WO2012120170A1 Method for determining alzheimer's disease by detection of glycoproteins carrying the hnk-1 glycoepitope
09/13/2012WO2012120151A1 Atip3 and biologically active fragments thereof for use in the treatment of cancer
09/13/2012WO2012120129A1 Methods and pharmaceutical composition for the treatment of infectious diseases
09/13/2012WO2012120026A1 Method for identifying a subset of polynucleotides from an initial set of polynucleotides corresponding to the human genome for the in vitro determination of the severity of the host response of a patient
09/13/2012WO2012119945A1 Novel methods for detecting hydroxymethylcytosine
09/13/2012WO2012119471A1 Detection method of small rna with high specificity
09/13/2012WO2012119231A1 Catalytic nucleic acid probes as microbial indicators
09/13/2012WO2012104851A9 Methods of diagnosing disease using overlap extension pcr
09/13/2012WO2012100133A3 Electrode compositions for use with analyte sensors
09/13/2012WO2012097849A3 Mitochondrial genome-restricted dna sequences
09/13/2012WO2012096579A3 Paired end random sequence based genotyping
09/13/2012WO2012083225A4 System and methods for massively parallel analysis of nycleic acids in single cells
09/13/2012WO2012082821A3 Melanoma treatments
09/13/2012WO2012078773A3 Optimized probes and primers and methods of using same for the detection, screening, isolation and sequencing of mrsa, mssa, staphylococcus markers, and the antibiotic resistance gene mec a
09/13/2012WO2012075046A9 Assays and biomarkers for lrrk2
09/13/2012WO2012073494A3 Sugarcane-stalk-diameter-related marker and the use thereof
09/13/2012WO2012061914A3 Method and kit for diagnosing neuropsychiatric conditions, method for evaluating treatments of neuropsychiatric conditions, and method for identifying pharmaceuticals that are potentially useful for the treatment of neuropsychiatric conditions
09/13/2012WO2011135058A3 Methods for detecting epigenetic modifications
09/13/2012WO2008046609A3 Synthesis and compositions of nucleic acids comprising 2'-terminator nucleotides
09/13/2012US20120233714 Non-human mammalian animal model for type 2 diabetes
09/13/2012US20120233713 Methods and systems for inducible ablation of neural cells
09/13/2012US20120232121 Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders
09/13/2012US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene
09/13/2012US20120232045 Methods and systems for prognosis of a patient's response to treatment of androgenetic skin disorders
09/13/2012US20120231968 Comparative Genomic Hybridization Assays Using Immobilized Oligonucleotide Features and Compositions for Practicing the Same
09/13/2012US20120231964 Method for selecting nucleic acids that bond with high-affinity to a target
09/13/2012US20120231961 Methods and systems for spores detection
09/13/2012US20120231959 Personalized medical management system, networks, and methods
09/13/2012US20120231526 Method for the Purification of Alphavirus Replicon Particles
09/13/2012US20120231522 Amplicon Melting Analysis With Saturation Dyes
09/13/2012US20120231490 Method Of Differentiation From Stem Cells To Hepatocytes
09/13/2012US20120231488 Fluid sample collection device
09/13/2012US20120231487 Method for preparing an invasive test of an egg and for determining a gender of an embryo in an egg
09/13/2012US20120231485 Method for monitoring anticoagulant therapy
09/13/2012US20120231482 Method, kit or diagnostic for the detection of reagents which induce altered contractility
09/13/2012US20120231479 Combination methods of diagnosing cancer in a patient
09/13/2012US20120231470 Methods and systems associated with detection of fatty acid elongation in a cell
09/13/2012US20120231469 Formalin-fixed isotope-labeled reference standards and methods for fabrication and use thereof
09/13/2012US20120231468 Rna from cytology samples to diagnose disease
09/13/2012US20120231467 Aptamers for C. Difficile Diagnostics
09/13/2012US20120231466 Methods and compositions for isolating nucleic acid
09/13/2012US20120231464 Heatable Droplet Device
09/13/2012US20120231463 Primer Set for Amplification of MTHFR Gene, MTHFR Gene Amplification Reagent Containing the Same, and Use of the Same
09/13/2012US20120231462 Artificial base pair capable of forming specific base pair
09/13/2012US20120231461 Detection of nucleic acids
09/13/2012US20120231460 Method and Apparatus for Predicting Pharmacological Efficacy of Human Anti-TNFa Antibody Drug against Rheumatoid Arthritis
09/13/2012US20120231458 Method of acquiring standard curve in real-time pcr
09/13/2012US20120231457 Compositions and methods for assessing a genetic risk of developing late-onset alzheimer's disease (load)
09/13/2012US20120231455 Peptide nucleic acid probes, kit and method for detecting helicobacter pylori and/or clarithromycin resistance profile and applications
09/13/2012US20120231454 Production of beta-cells